Lanean...
Using Molecular Markers to Guide Therapy of Metastatic Colorectal Cancer
Colorectal cancer remains one of the most commonly diagnosed cancers with almost one-fourth of patients presenting with metastatic disease at the time of diagnosis. As the repertoire of anticancer agents has expanded to treat colorectal patients with metastatic disease, life expectancies have increa...
Gorde:
| Argitaratua izan da: | J Oncopathol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2013
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4667749/ https://ncbi.nlm.nih.gov/pubmed/26640695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.13032/tjop.2052-5931.100056 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|